Melanoma-Specific Antigens
"Melanoma-Specific Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cellular antigens that are specific for MELANOMA cells.
| Descriptor ID |
D058950
|
| MeSH Number(s) |
D12.776.624.301 D23.050.285.439
|
| Concept/Terms |
Melanoma-Specific Antigens- Melanoma-Specific Antigens
- Antigens, Melanoma-Specific
- Melanoma Specific Antigens
- Melanoma Antigens
- Antigens, Melanoma
|
Below are MeSH descriptors whose meaning is more general than "Melanoma-Specific Antigens".
Below are MeSH descriptors whose meaning is more specific than "Melanoma-Specific Antigens".
This graph shows the total number of publications written about "Melanoma-Specific Antigens" by people in this website by year, and whether "Melanoma-Specific Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma-Specific Antigens" by people in Profiles.
-
Zand S, Buzney E, Duncan LM, Dadras SS. Heterogeneity of Metastatic Melanoma: ?Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1. Am J Clin Pathol. 2016 Sep; 146(3):353-60.
-
Chakraborty NG, Yadav M, Dadras SS, Singh P, Chhabra A, Feinn R, Kerr PE, Grant-Kels JM, Mukherji B, Hegde UP. Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly. Hum Immunol. 2013 May; 74(5):640-7.
-
Zembowicz A, Yang SE, Kafanas A, Lyle SR. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. Arch Pathol Lab Med. 2012 Dec; 136(12):1571-9.
-
Caballero OL, Zhao Q, Rimoldi D, Stevenson BJ, Svobodov? S, Devalle S, R?hrig UF, Pagotto A, Michielin O, Speiser D, Wolchok JD, Liu C, Pejovic T, Odunsi K, Brasseur F, Van den Eynde BJ, Old LJ, Lu X, Cebon J, Strausberg RL, Simpson AJ. Frequent MAGE mutations in human melanoma. PLoS One. 2010 Sep 16; 5(9).
-
Dhodapkar MV, Osman K, Teruya-Feldstein J, Filippa D, Hedvat CV, Iversen K, Kolb D, Geller MD, Hassoun H, Kewalramani T, Comenzo RL, Coplan K, Chen YT, Jungbluth AA. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease. Cancer Immun. 2003 Jul 23; 3:9.